Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improvement of vanishing bile duct syndrome with hyperlipidemia.
Yamauchi R, Takata K, Fukunaga A, Tanaka T, Yokoyama K, Shakado S, Nabeshima K, Yoshimitsu K, Hirai F. Yamauchi R, et al. Among authors: fukunaga a. Clin J Gastroenterol. 2022 Aug;15(4):784-790. doi: 10.1007/s12328-022-01650-4. Epub 2022 Jul 8. Clin J Gastroenterol. 2022. PMID: 35802301
Eosinophilic gastroenteritis in a patient with chronic hepatitis C who received treatment with pegylated interferon.
Hirano G, Fukunaga A, Sohda T, Kunimoto H, Yotsumoto K, Sakurai K, Iwashita H, Ueda S, Yokoyama K, Morihara D, Tomioka Y, Anan A, Yamaguchi M, Takeyama Y, Eguchi K, Sakamoto M, Irie M, Iwata K, Shakado S, Aoyagi K, Sakisaka S. Hirano G, et al. Among authors: fukunaga a. Clin J Gastroenterol. 2012 Apr;5(2):127-30. doi: 10.1007/s12328-012-0289-2. Epub 2012 Feb 24. Clin J Gastroenterol. 2012. PMID: 26182155
A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin.
Shakado S, Akehi Y, Yotsumoto K, Fukunaga A, Kuno S, Tanaka T, Sakurai K, Iwashita H, Ueda S, Hirano G, Yokoyama K, Morihara D, Nishizawa S, Sakamoto M, Anan A, Takeyama Y, Irie M, Iwata K, Sohda T, Sakisaka S. Shakado S, et al. Among authors: fukunaga a. Clin J Gastroenterol. 2011 Aug;4(4):255-261. doi: 10.1007/s12328-011-0228-7. Epub 2011 Jun 10. Clin J Gastroenterol. 2011. PMID: 26189530
Reduced Glutathione suppresses Oxidative Stress in Nonalcoholic Fatty Liver Disease.
Irie M, Sohda T, Anan A, Fukunaga A, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S. Irie M, et al. Among authors: fukunaga a. Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):13-18. doi: 10.5005/jp-journals-10018-1159. Epub 2016 Jul 9. Euroasian J Hepatogastroenterol. 2016. PMID: 29201718 Free PMC article.
Oxidative stress may also contribute to clinical progression from simple fatty liver (FL) to NASH. A therapy for insulin resistance and antioxidant has been applied to treat NASH, yet these treatments are not fully established. ...DISCUSSION: The present pilot study demons …
Oxidative stress may also contribute to clinical progression from simple fatty liver (FL) to NASH. A therapy for insulin resistance a …
IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment.
Morihara D, Ko YL, Shibata K, Yamauchi R, Fukuda H, Tsuchiya N, Fukunaga A, Kunimoto H, Iwashita H, Takata K, Tanaka T, Sakurai K, Inomata S, Yokoyama K, Nishizawa S, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S. Morihara D, et al. Among authors: fukunaga a. J Gastroenterol Hepatol. 2019 Nov;34(11):2019-2027. doi: 10.1111/jgh.14741. Epub 2019 Jun 21. J Gastroenterol Hepatol. 2019. PMID: 31144350
Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate.
Yamauchi R, Takeyama Y, Takata K, Fukunaga A, Sakurai K, Tanaka T, Fukuda H, Fukuda S, Kunimoto H, Umeda K, Morihara D, Yokoyama K, Irie M, Shakado S, Sakisaka S, Hirai F. Yamauchi R, et al. Among authors: fukunaga a. Intern Med. 2020 May 1;59(9):1163-1166. doi: 10.2169/internalmedicine.3805-19. Epub 2020 Jan 17. Intern Med. 2020. PMID: 31956202 Free PMC article.
Eosinophilic Granuloma of the Liver Mimicking Metastatic Liver Tumor.
Uchida Y, Yokoyama K, Higashi T, Kitaguchi T, Fukuda H, Yamauchi R, Tsuchiya N, Fukunaga A, Umeda K, Takata K, Tanaka T, Takeyama Y, Shakado S, Sakisaka S, Hayashi H, Hamada Y, Nabeshima K, Hirai F. Uchida Y, et al. Among authors: fukunaga a. Intern Med. 2022 May 15;61(10):1511-1517. doi: 10.2169/internalmedicine.8438-21. Epub 2021 Oct 19. Intern Med. 2022. PMID: 34670905 Free PMC article.
Pretreatment Modified Albumin-Bilirubin Grade Is an Important Predictive Factor Associated with the Therapeutic Response and the Continuation of Atezolizumab plus Bevacizumab Combination Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Tanaka T, Takata K, Yokoyama K, Fukuda H, Yamauchi R, Fukunaga A, Shakado S, Sakisaka S, Hirai F. Tanaka T, et al. Among authors: fukunaga a. Curr Oncol. 2022 Jul 8;29(7):4799-4810. doi: 10.3390/curroncol29070381. Curr Oncol. 2022. PMID: 35877241 Free PMC article.
Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites.
Yokoyama K, Fukuda H, Yamauchi R, Higashi M, Miyayama T, Higashi T, Uchida Y, Shibata K, Tsuchiya N, Fukunaga A, Umeda K, Takata K, Tanaka T, Shakado S, Sakisaka S, Hirai F. Yokoyama K, et al. Among authors: fukunaga a. Medicina (Kaunas). 2022 Sep 14;58(9):1276. doi: 10.3390/medicina58091276. Medicina (Kaunas). 2022. PMID: 36143954 Free PMC article.
Long-term outcomes of hemostatic therapy for variceal bleeding and the challenge pending in the post-direct-acting antivirals era.
Shibata K, Yokoyama K, Yamauchi R, Matsumoto K, Himeno S, Nagata T, Higashi T, Kitaguchi T, Fukuda H, Tsuchiya N, Fukunaga A, Takata K, Tanaka T, Takeyama Y, Shakado S, Sakisaka S, Hirai F. Shibata K, et al. Among authors: fukunaga a. Acta Gastroenterol Belg. 2022 Jan-Mar;85(1):7-14. doi: 10.51821/85.1.9276. Acta Gastroenterol Belg. 2022. PMID: 35304988 Free article.
387 results